Literature DB >> 16879879

Easy and fast detection and genotyping of high-risk human papillomavirus by dedicated DNA microarrays.

Valérie Albrecht1, Anne Chevallier, Virginie Magnone, Pascal Barbry, Fanny Vandenbos, André Bongain, Jean-Claude Lefebvre, Valérie Giordanengo.   

Abstract

Persistent cervical high-risk human papillomavirus (HPV) infection is correlated with an increased risk of developing a high-grade cervical intraepithelial lesion. A two-step method was developed for detection and genotyping of high-risk HPV. DNA was firstly amplified by asymmetrical PCR in the presence of Cy3-labelled primers and dUTP. Labelled DNA was then genotyped using DNA microarray hybridization. The current study evaluated the technical efficacy of laboratory-designed HPV DNA microarrays for high-risk HPV genotyping on 57 malignant and non-malignant cervical smears. The approach was evaluated for a broad range of cytological samples: high-grade squamous intraepithelial lesions (HSIL), low-grade squamous intraepithelial lesions (LSIL) and atypical squamous cells of high-grade (ASC-H). High-risk HPV was also detected in six atypical squamous cells of undetermined significance (ASC-US) samples; among them only one cervical specimen was found uninfected, associated with no histological lesion. The HPV oligonucleotide DNA microarray genotyping detected 36 infections with a single high-risk HPV type and 5 multiple infections with several high-risk types. Taken together, these results demonstrate the sensitivity and specificity of the HPV DNA microarray approach. This approach could improve clinical management of patients with cervical cytological abnormalities.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16879879     DOI: 10.1016/j.jviromet.2006.06.023

Source DB:  PubMed          Journal:  J Virol Methods        ISSN: 0166-0934            Impact factor:   2.014


  8 in total

Review 1.  Basic concepts of microarrays and potential applications in clinical microbiology.

Authors:  Melissa B Miller; Yi-Wei Tang
Journal:  Clin Microbiol Rev       Date:  2009-10       Impact factor: 26.132

2.  Dramatic increase in the signal and sensitivity of detection via self-assembly of branched DNA.

Authors:  Kyung-Tae Kim; Chi-Bom Chae
Journal:  Mol Cells       Date:  2011-08-23       Impact factor: 5.034

Review 3.  Cutaneous squamous cell carcinoma and human papillomavirus: is there an association?

Authors:  Bishr Aldabagh; Jorge Gil C Angeles; Adela R Cardones; Sarah T Arron
Journal:  Dermatol Surg       Date:  2012-08-28       Impact factor: 3.398

4.  Detection of human papillomaviruses by polymerase chain reaction and ligation reaction on universal microarray.

Authors:  Jarmo Ritari; Jenni Hultman; Rita Fingerroos; Jussi Tarkkanen; Janne Pullat; Lars Paulin; Niina Kivi; Petri Auvinen; Eeva Auvinen
Journal:  PLoS One       Date:  2012-03-23       Impact factor: 3.240

5.  Validation of a diagnostic microarray for human papillomavirus: coverage of 102 genotypes.

Authors:  Sarah Tuttleton Arron; Peter Skewes-Cox; Phong H Do; Eric Dybbro; Maria Da Costa; Joel M Palefsky; Joseph L Derisi
Journal:  J Nucleic Acids       Date:  2011-05-18

6.  Resequencing microarray technology for genotyping human papillomavirus in cervical smears.

Authors:  Nicolas Berthet; Michael Falguières; Claudia Filippone; Chloé Bertolus; Christine Bole-Feysot; Sylvain Brisse; Antoine Gessain; Isabelle Heard; Michel Favre
Journal:  PLoS One       Date:  2014-11-10       Impact factor: 3.240

Review 7.  Molecular methods for pathogen and microbial community detection and characterization: current and potential application in diagnostic microbiology.

Authors:  Christopher D Sibley; Gisele Peirano; Deirdre L Church
Journal:  Infect Genet Evol       Date:  2012-02-09       Impact factor: 3.342

8.  Development of a consensus microarray method for identification of some highly pathogenic viruses.

Authors:  Kang Xiao-Ping; Li Yong-Qiang; Sun Qing-Ge; Liu Hong; Zhu Qing-Yu; Yang Yin-Hui
Journal:  J Med Virol       Date:  2009-11       Impact factor: 2.327

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.